Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Issues related to making Health Savings Accounts and Health Reimbursement Arrangements more accessible and ubiquitous, including H.R. 548- HSA Modernization Act, H.R.919 - Chronic Disease Flexible Coverage Act, S. 2875 - Custom Health Option and Individual Care Expense (CHOICE) Act, H.R. 5463 - Choice Arrangement Act, S.2875 - CHOICE Act H.R.1157 - ACCESS Act
Mikaela Naylon Give Kids a Chance Act
Client: FULCRUM THERAPEUTICS · Firm: THE MCMANUS GROUP
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ZIMMER BIOMET via THE MCMANUS GROUP
2026 · third_quarter · Q3
Access and reimbursement of medical devices in Medicare program. Issues related to capping beneficiary copayments for Medicare beneficiaries in ambulatory surgery centers, included in Medicare Beneficiary Co-Pay Fairness Act of 2025(H.R. 3006/S. 1776) The Ensuring Patient Access to Critical Breakthrough Products Act (H.R. 5343/S. 1717)
Issues related to Artificial Intelligences approval in Medical Devices. Issues related to The SECURE Data Act (H.R. 8413).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| ROCHE DIAGNOSTICS |
| 2 |
| 2026 |
| WEX HEALTH | 2 | 2026 |
| zimmer biomet | 2 | 2026 |
| DENDREON PHARMACEUTICALS, LLC | 1 | 2026 |
| LARGE UROLOGY GROUP PRACTICE ASSOCIATION | 1 | 2026 |
| VIALASE INC. | 1 | 2026 |
Education and advocacy regarding sickle cell disease, including H.R. 1796/S. 735- Sickle Cell Disease and Other Heritable Blood Disorders, Research, Surveillance, Prevention, and Treatment Act of 2025. Priority review vouchers: Give Kids a Chance Act of 2025 (H.R. 1262/S.932) Issues related to FDA Accelerated Approval Pathways
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
Client: FULCRUM THERAPEUTICS · Firm: THE MCMANUS GROUP
Education and advocacy regarding sickle cell disease, including H.R. 1796/S. 735- Sickle Cell Disease and Other Heritable Blood Disorders, Research, Surveillance, Prevention, and Treatment Act of 2025.
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
Client: FULCRUM THERAPEUTICS · Firm: THE MCMANUS GROUP
Education and advocacy regarding sickle cell disease, including H.R. 1796/S. 735- Sickle Cell Disease and Other Heritable Blood Disorders, Research, Surveillance, Prevention, and Treatment Act of 2025. Priority review vouchers: Give Kids a Chance Act of 2025 (H.R. 1262/S.932) Issues related to FDA Accelerated Approval Pathways
H.R. 2168/S.3712, Baby Observation (BO's) Act
H.R. 2168/S.3712, Baby Observation (BO's) Act
H.R. 2168/S.3712, Baby Observation (BO's) Act
H.R. 2168/S.3712, Baby Observation (BO's) Act
Seniors’ Access to Critical Medications Act of 2025
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION · Firm: THE MCMANUS GROUP
Issues related to access and physician reimbursement under Medicare Part B, including H.R. 879 - Medicare Patient Access and Practice Stabilization Act; H.R. 2474 - Strengthening Medicare for Patients and Providers Act; S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025 Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. H.R. 2484- Seniors' Access to Critical Medications Act of 2025. Issues related to prior authorization. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act Issues related to stark regulation of in office dispensing of Part D drugs. Issues related to the Provider Reimbursement Stability Act of 2026 (H.R.8163). Issues related to the Patients First Act of 2026 (H.R.9693)
To amend title XVIII of the Social Security Act to limit the coinsurance amount for certain services furnished in an ambulatory surgical center.
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Advocacy for increased patient access and reimbursement to ambulatory surgical centers. Issues related to Medicare beneficiary patients to ASCs. Medicare Beneficiary Co-Pay Fairness Act of 2025 (H.R. 3006/S. 1776) Outpatient Surgery Access Act of 2026 (H.R. 8091)
To amend title XVIII of the Social Security Act to limit the coinsurance amount for certain services furnished in an ambulatory surgical center.
Client: ZIMMER BIOMET · Firm: THE MCMANUS GROUP
Access and reimbursement of medical devices in Medicare program. Issues related to capping beneficiary copayments for Medicare beneficiaries in ambulatory surgery centers, included in Medicare Beneficiary Co-Pay Fairness Act of 2025(H.R. 3006/S. 1776) The Ensuring Patient Access to Critical Breakthrough Products Act (H.R. 5343/S. 1717)
To amend title XVIII of the Social Security Act to limit the coinsurance amount for certain services furnished in an ambulatory surgical center.
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Advocacy for increased patient access and reimbursement to ambulatory surgical centers. Issues related to Medicare beneficiary patients to ASCs. Medicare Beneficiary Co-Pay Fairness Act of 2025 (H.R. 3006/S. 1776) Outpatient Surgery Access Act of 2026 (H.R. 8091)
To amend title XVIII of the Social Security Act to limit the coinsurance amount for certain services furnished in an ambulatory surgical center.
Client: ZIMMER BIOMET · Firm: THE MCMANUS GROUP
Access and reimbursement of medical devices in Medicare program. Issues related to capping beneficiary copayments for Medicare beneficiaries in ambulatory surgery centers, included in Medicare Beneficiary Co-Pay Fairness Act of 2025(H.R. 3006/S. 1776) The Ensuring Patient Access to Critical Breakthrough Products Act (H.R. 5343/S. 1717)
To amend title XVIII of the Social Security Act to limit the coinsurance amount for certain services furnished in an ambulatory surgical center.
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Advocacy for increased patient access and reimbursement to ambulatory surgical centers. Issues related to Medicare payment and beneficiary patients to ASCs. Medicare Beneficiary Co-Pay Fairness Act of 2025 (H.R. 3006/S. 1776) Outpatient Surgery Access Act of 2026 (H.R. 8091) Promoting Fairness for Medicare Providers Act of 2026 (H.R. 7863)
Emergency Care Improvement Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers, including H.R. 3134, the Emergency Care Improvement Act.
Emergency Care Improvement Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers, including H.R. 3134, the Emergency Care Improvement Act.
Emergency Care Improvement Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers, including H.R. 3134, the Emergency Care Improvement Act.
Protecting Patient Access to Cancer and Complex Therapies Act
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION · Firm: THE MCMANUS GROUP
Issues related to access and physician reimbursement under Medicare Part B, including H.R. 879 - Medicare Patient Access and Practice Stabilization Act; H.R. 2474 - Strengthening Medicare for Patients and Providers Act; S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025 Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. H.R. 2484- Seniors' Access to Critical Medications Act of 2025. Issues related to prior authorization. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act Issues related to stark regulation of in office dispensing of Part D drugs. Issues related to the Provider Reimbursement Stability Act of 2026 (H.R.8163). Issues related to the Patients First Act of 2026 (H.R.9693)
No Surprises Act Enforcement Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Issues relating to the implementation of provisions included in Subtitle BB of PL.116-260- No Surprises Act, including the No Surprises Act Enforcement Act (H.R. 4710/S. 2420). Issues relating to the Federal Independent Dispute Resolution Operations proposed rule
No Surprises Act Enforcement Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Issues relating to the implementation of provisions included in Subtitle BB of PL.116-260- No Surprises Act, including the No Surprises Act Enforcement Act (H.R. 4710/S. 2420). Issues relating to the Federal Independent Dispute Resolution Operations proposed rule
No Surprises Act Enforcement Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Issues relating to the implementation of provisions included in Subtitle BB of PL.116-260- No Surprises Act, including the No Surprises Act Enforcement Act (H.R. 4710/S. 2420). Issues relating to the Federal Independent Dispute Resolution Operations proposed rule
H.R.5269/2761 - RESULTS Act Issues related to Medicare coverage and reimbursement for FDA-designated breakthrough medical devices, focusing on establishing a transitional coverage period, including H.R. 5343/S. 1717- Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
H.R.5269/2761 - RESULTS Act Issues related to Medicare coverage and reimbursement for FDA-designated breakthrough medical devices, focusing on establishing a transitional coverage period, including H.R. 5343/S. 1717- Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Ensuring Patient Access to Critical Breakthrough Products Act
Client: ROCHE DIAGNOSTICS · Firm: THE MCMANUS GROUP
H.R.5269/2761 - RESULTS Act Issues related to Medicare coverage and reimbursement for FDA-designated breakthrough medical devices, focusing on establishing a transitional coverage period, including H.R. 5343/S. 1717- Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Ensuring Patient Access to Critical Breakthrough Products Act
Client: ZIMMER BIOMET · Firm: THE MCMANUS GROUP
Access and reimbursement of medical devices in Medicare program. Issues related to capping beneficiary copayments for Medicare beneficiaries in ambulatory surgery centers, included in Medicare Beneficiary Co-Pay Fairness Act of 2025(H.R. 3006/S. 1776) The Ensuring Patient Access to Critical Breakthrough Products Act (H.R. 5343/S. 1717)
Ensuring Patient Access to Critical Breakthrough Products Act
Client: ZIMMER BIOMET · Firm: THE MCMANUS GROUP
Access and reimbursement of medical devices in Medicare program. Issues related to capping beneficiary copayments for Medicare beneficiaries in ambulatory surgery centers, included in Medicare Beneficiary Co-Pay Fairness Act of 2025(H.R. 3006/S. 1776) The Ensuring Patient Access to Critical Breakthrough Products Act (H.R. 5343/S. 1717)
Ensuring Patient Access to Critical Breakthrough Products Act
Client: ROCHE DIAGNOSTICS · Firm: THE MCMANUS GROUP
H.R.5269/2761 - RESULTS Act Issues related to Medicare coverage and reimbursement for FDA-designated breakthrough medical devices, focusing on establishing a transitional coverage period, including H.R. 5343/S. 1717- Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Issues related to making Health Savings Accounts and Health Reimbursement Arrangements more accessible and ubiquitous, including H.R. 548- HSA Modernization Act, H.R.919 - Chronic Disease Flexible Coverage Act, S. 2875 - Custom Health Option and Individual Care Expense (CHOICE) Act, H.R. 5463 - Choice Arrangement Act, S.2875 - CHOICE Act
Issues related to making Health Savings Accounts and Health Reimbursement Arrangements more accessible and ubiquitous, including H.R. 548- HSA Modernization Act, H.R.919 - Chronic Disease Flexible Coverage Act, S. 2875 - Custom Health Option and Individual Care Expense (CHOICE) Act, H.R. 5463 - Choice Arrangement Act, S.2875 - CHOICE Act H.R.1157 - ACCESS Act
Issues related to making Health Savings Accounts and Health Reimbursement Arrangements more accessible and ubiquitous, including H.R. 548- HSA Modernization Act, H.R.919 - Chronic Disease Flexible Coverage Act, S. 2875 - Custom Health Option and Individual Care Expense (CHOICE) Act, H.R. 5463 - Choice Arrangement Act, S.2875 - CHOICE Act H.R.1157 - ACCESS Act
Issues related to making Health Savings Accounts and Health Reimbursement Arrangements more accessible and ubiquitous, including H.R. 548- HSA Modernization Act, H.R.919 - Chronic Disease Flexible Coverage Act, S. 2875 - Custom Health Option and Individual Care Expense (CHOICE) Act, H.R. 5463 - Choice Arrangement Act, S.2875 - CHOICE Act
Patients Deserve Price Tags Act
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Issues related to site neutrality. Issues related to provider and insurer payment transparency. S.1629 - Same Care, Lower Cost Act. S.2355/H.R.5582 - Patients Deserve Price Tags Act. Issues related to Lower Costs, More Transparency Act of 2026 (H.R.9393)
Patients Deserve Price Tags Act
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Issues related to site neutrality. Issues related to provider and insurer payment transparency. S.1629 - Same Care, Lower Cost Act. Issues related to Patients Deserve Price Tags Act (S.2355/H.R.5582). Issues related to Lower Costs, More Transparency Act of 2026 (H.R.9393). Issues related to Health Care Price Certainty for All Americans Act (H.R.9645).
Issues related to the 2025 End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) Final Rule (CMS-105-F), specifically the inclusion of oral-only drugs in the ESRD PPS Bundled Payment. H.R.6214 - Kidney Care Access Protection Act Issues related to Most Favored Nation Drug Pricing Reform
Promoting Fairness for Medicare Providers Act of 2026
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Advocacy for increased patient access and reimbursement to ambulatory surgical centers. Issues related to Medicare payment and beneficiary patients to ASCs. Medicare Beneficiary Co-Pay Fairness Act of 2025 (H.R. 3006/S. 1776) Outpatient Surgery Access Act of 2026 (H.R. 8091) Promoting Fairness for Medicare Providers Act of 2026 (H.R. 7863)
Outpatient Surgery Access Act of 2026
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Advocacy for increased patient access and reimbursement to ambulatory surgical centers. Issues related to Medicare beneficiary patients to ASCs. Medicare Beneficiary Co-Pay Fairness Act of 2025 (H.R. 3006/S. 1776) Outpatient Surgery Access Act of 2026 (H.R. 8091)
Outpatient Surgery Access Act of 2026
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Advocacy for increased patient access and reimbursement to ambulatory surgical centers. Issues related to Medicare beneficiary patients to ASCs. Medicare Beneficiary Co-Pay Fairness Act of 2025 (H.R. 3006/S. 1776) Outpatient Surgery Access Act of 2026 (H.R. 8091)
Outpatient Surgery Access Act of 2026
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Advocacy for increased patient access and reimbursement to ambulatory surgical centers. Issues related to Medicare payment and beneficiary patients to ASCs. Medicare Beneficiary Co-Pay Fairness Act of 2025 (H.R. 3006/S. 1776) Outpatient Surgery Access Act of 2026 (H.R. 8091) Promoting Fairness for Medicare Providers Act of 2026 (H.R. 7863)
Provider Reimbursement Stability Act of 2026
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION · Firm: THE MCMANUS GROUP
Issues related to access and physician reimbursement under Medicare Part B, including H.R. 879 - Medicare Patient Access and Practice Stabilization Act; H.R. 2474 - Strengthening Medicare for Patients and Providers Act; S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025 Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. H.R. 2484- Seniors' Access to Critical Medications Act of 2025. Issues related to prior authorization. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act Issues related to stark regulation of in office dispensing of Part D drugs. Issues related to the Provider Reimbursement Stability Act of 2026 (H.R.8163). Issues related to the Patients First Act of 2026 (H.R.9693)
Issues related to Artificial Intelligences approval in Medical Devices. Issues related to The SECURE Data Act (H.R. 8413).
Issues related to Artificial Intelligences approval in Medical Devices. Issues related to The SECURE Data Act (H.R. 8413).
Medicare Patient Access and Practice Stabilization Act of 2025
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION · Firm: THE MCMANUS GROUP
Issues related to access and physician reimbursement under Medicare Part B, including H.R. 879 - Medicare Patient Access and Practice Stabilization Act; H.R. 2474 - Strengthening Medicare for Patients and Providers Act; S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025 Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. H.R. 2484- Seniors' Access to Critical Medications Act of 2025. Issues related to prior authorization. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act Issues related to stark regulation of in office dispensing of Part D drugs. Issues related to the Provider Reimbursement Stability Act of 2026 (H.R.8163). Issues related to the Patients First Act of 2026 (H.R.9693)
Issues related to making Health Savings Accounts and Health Reimbursement Arrangements more accessible and ubiquitous, including H.R. 548- HSA Modernization Act, H.R.919 - Chronic Disease Flexible Coverage Act, S. 2875 - Custom Health Option and Individual Care Expense (CHOICE) Act, H.R. 5463 - Choice Arrangement Act, S.2875 - CHOICE Act H.R.1157 - ACCESS Act
Issues related to making Health Savings Accounts and Health Reimbursement Arrangements more accessible and ubiquitous, including H.R. 548- HSA Modernization Act, H.R.919 - Chronic Disease Flexible Coverage Act, S. 2875 - Custom Health Option and Individual Care Expense (CHOICE) Act, H.R. 5463 - Choice Arrangement Act, S.2875 - CHOICE Act
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: OWLET · Firm: THE MCMANUS GROUP
Issues related to infant monitoring in H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: OWLET · Firm: THE MCMANUS GROUP
Issues related to infant monitoring in H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Lower Costs, More Transparency Act of 2026
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Issues related to site neutrality. Issues related to provider and insurer payment transparency. S.1629 - Same Care, Lower Cost Act. Issues related to Patients Deserve Price Tags Act (S.2355/H.R.5582). Issues related to Lower Costs, More Transparency Act of 2026 (H.R.9393). Issues related to Health Care Price Certainty for All Americans Act (H.R.9645).
Lower Costs, More Transparency Act of 2026
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Issues related to site neutrality. Issues related to provider and insurer payment transparency. S.1629 - Same Care, Lower Cost Act. S.2355/H.R.5582 - Patients Deserve Price Tags Act. Issues related to Lower Costs, More Transparency Act of 2026 (H.R.9393)
Health Care Price Certainty for All Americans Act
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Issues related to site neutrality. Issues related to provider and insurer payment transparency. S.1629 - Same Care, Lower Cost Act. Issues related to Patients Deserve Price Tags Act (S.2355/H.R.5582). Issues related to Lower Costs, More Transparency Act of 2026 (H.R.9393). Issues related to Health Care Price Certainty for All Americans Act (H.R.9645).
Patients First Act of 2026
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION · Firm: THE MCMANUS GROUP
Issues related to access and physician reimbursement under Medicare Part B, including H.R. 879 - Medicare Patient Access and Practice Stabilization Act; H.R. 2474 - Strengthening Medicare for Patients and Providers Act; S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025 Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. H.R. 2484- Seniors' Access to Critical Medications Act of 2025. Issues related to prior authorization. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act Issues related to stark regulation of in office dispensing of Part D drugs. Issues related to the Provider Reimbursement Stability Act of 2026 (H.R.8163). Issues related to the Patients First Act of 2026 (H.R.9693)
Same Care, Lower Cost Act
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Issues related to site neutrality. Issues related to provider and insurer payment transparency. S.1629 - Same Care, Lower Cost Act. Issues related to Patients Deserve Price Tags Act (S.2355/H.R.5582). Issues related to Lower Costs, More Transparency Act of 2026 (H.R.9393). Issues related to Health Care Price Certainty for All Americans Act (H.R.9645).
Same Care, Lower Cost Act
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Issues related to site neutrality. Issues related to provider and insurer payment transparency. S.1629 - Same Care, Lower Cost Act. S.2355/H.R.5582 - Patients Deserve Price Tags Act. Issues related to Lower Costs, More Transparency Act of 2026 (H.R.9393)
Same Care, Lower Cost Act
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Issues related to site neutrality. Issues related to provider and insurer payment transparency. S.1629 - Same Care, Lower Cost Act. S.2355 - Patients Deserve Price Tags Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION · Firm: THE MCMANUS GROUP
Issues related to access and physician reimbursement under Medicare Part B, including H.R. 879 - Medicare Patient Access and Practice Stabilization Act; H.R. 2474 - Strengthening Medicare for Patients and Providers Act; S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025 Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. H.R. 2484- Seniors' Access to Critical Medications Act of 2025. Issues related to prior authorization. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act Issues related to stark regulation of in office dispensing of Part D drugs. Issues related to the Provider Reimbursement Stability Act of 2026 (H.R.8163). Issues related to the Patients First Act of 2026 (H.R.9693)
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: ROCHE DIAGNOSTICS · Firm: THE MCMANUS GROUP
H.R.5269/2761 - RESULTS Act Issues related to Medicare coverage and reimbursement for FDA-designated breakthrough medical devices, focusing on establishing a transitional coverage period, including H.R. 5343/S. 1717- Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: ROCHE DIAGNOSTICS · Firm: THE MCMANUS GROUP
H.R.5269/2761 - RESULTS Act Issues related to Medicare coverage and reimbursement for FDA-designated breakthrough medical devices, focusing on establishing a transitional coverage period, including H.R. 5343/S. 1717- Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: ZIMMER BIOMET · Firm: THE MCMANUS GROUP
Access and reimbursement of medical devices in Medicare program. Issues related to capping beneficiary copayments for Medicare beneficiaries in ambulatory surgery centers, included in Medicare Beneficiary Co-Pay Fairness Act of 2025(H.R. 3006/S. 1776) The Ensuring Patient Access to Critical Breakthrough Products Act (H.R. 5343/S. 1717)
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: ZIMMER BIOMET · Firm: THE MCMANUS GROUP
Access and reimbursement of medical devices in Medicare program. Issues related to capping beneficiary copayments for Medicare beneficiaries in ambulatory surgery centers, included in Medicare Beneficiary Co-Pay Fairness Act of 2025(H.R. 3006/S. 1776) The Ensuring Patient Access to Critical Breakthrough Products Act (H.R. 5343/S. 1717)
Access and reimbursement of medical devices in Medicare program. Issues related to capping beneficiary copayments for Medicare beneficiaries in ambulatory surgery centers, included in Medicare Beneficiary Co-Pay Fairness Act of 2025(H.R. 3006/S. 1776) The Ensuring Patient Access to Critical Breakthrough Products Act (H.R. 5343/S. 1717)
Medicare Beneficiary Co-Pay Fairness Act
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Advocacy for increased patient access and reimbursement to ambulatory surgical centers. Issues related to Medicare beneficiary patients to ASCs. Medicare Beneficiary Co-Pay Fairness Act of 2025 (H.R. 3006/S. 1776) Outpatient Surgery Access Act of 2026 (H.R. 8091)
Medicare Beneficiary Co-Pay Fairness Act
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Advocacy for increased patient access and reimbursement to ambulatory surgical centers. Issues related to Medicare beneficiary patients to ASCs. Medicare Beneficiary Co-Pay Fairness Act of 2025 (H.R. 3006/S. 1776) Outpatient Surgery Access Act of 2026 (H.R. 8091)
Access and reimbursement of medical devices in Medicare program. Issues related to capping beneficiary copayments for Medicare beneficiaries in ambulatory surgery centers, included in Medicare Beneficiary Co-Pay Fairness Act of 2025(H.R. 3006/S. 1776) The Ensuring Patient Access to Critical Breakthrough Products Act (H.R. 5343/S. 1717)
Medicare Beneficiary Co-Pay Fairness Act
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Advocacy for increased patient access and reimbursement to ambulatory surgical centers. Issues related to Medicare payment and beneficiary patients to ASCs. Medicare Beneficiary Co-Pay Fairness Act of 2025 (H.R. 3006/S. 1776) Outpatient Surgery Access Act of 2026 (H.R. 8091) Promoting Fairness for Medicare Providers Act of 2026 (H.R. 7863)
Patients Deserve Price Tags Act
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Issues related to site neutrality. Issues related to provider and insurer payment transparency. S.1629 - Same Care, Lower Cost Act. Issues related to Patients Deserve Price Tags Act (S.2355/H.R.5582). Issues related to Lower Costs, More Transparency Act of 2026 (H.R.9393). Issues related to Health Care Price Certainty for All Americans Act (H.R.9645).
Patients Deserve Price Tags Act
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Issues related to site neutrality. Issues related to provider and insurer payment transparency. S.1629 - Same Care, Lower Cost Act. S.2355 - Patients Deserve Price Tags Act.
Patients Deserve Price Tags Act
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Issues related to site neutrality. Issues related to provider and insurer payment transparency. S.1629 - Same Care, Lower Cost Act. S.2355/H.R.5582 - Patients Deserve Price Tags Act. Issues related to Lower Costs, More Transparency Act of 2026 (H.R.9393)
No Surprises Act Enforcement Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Issues relating to the implementation of provisions included in Subtitle BB of PL.116-260- No Surprises Act, including the No Surprises Act Enforcement Act (H.R. 4710/S. 2420). Issues relating to the Federal Independent Dispute Resolution Operations proposed rule
No Surprises Act Enforcement Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Issues relating to the implementation of provisions included in Subtitle BB of PL.116-260- No Surprises Act, including the No Surprises Act Enforcement Act (H.R. 4710/S. 2420). Issues relating to the Federal Independent Dispute Resolution Operations proposed rule
No Surprises Act Enforcement Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Issues relating to the implementation of provisions included in Subtitle BB of PL.116-260- No Surprises Act, including the No Surprises Act Enforcement Act (H.R. 4710/S. 2420). Issues relating to the Federal Independent Dispute Resolution Operations proposed rule
Issues related to making Health Savings Accounts and Health Reimbursement Arrangements more accessible and ubiquitous, including H.R. 548- HSA Modernization Act, H.R.919 - Chronic Disease Flexible Coverage Act, S. 2875 - Custom Health Option and Individual Care Expense (CHOICE) Act, H.R. 5463 - Choice Arrangement Act, S.2875 - CHOICE Act H.R.1157 - ACCESS Act
Issues related to making Health Savings Accounts and Health Reimbursement Arrangements more accessible and ubiquitous, including H.R. 548- HSA Modernization Act, H.R.919 - Chronic Disease Flexible Coverage Act, S. 2875 - Custom Health Option and Individual Care Expense (CHOICE) Act, H.R. 5463 - Choice Arrangement Act, S.2875 - CHOICE Act
H.R. 2168/S.3712, Baby Observation (BO's) Act
H.R. 2168/S.3712, Baby Observation (BO's) Act
H.R. 2168/S.3712, Baby Observation (BO's) Act
H.R. 2168/S.3712, Baby Observation (BO's) Act
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
Client: FULCRUM THERAPEUTICS · Firm: THE MCMANUS GROUP
Education and advocacy regarding sickle cell disease, including H.R. 1796/S. 735- Sickle Cell Disease and Other Heritable Blood Disorders, Research, Surveillance, Prevention, and Treatment Act of 2025. Priority review vouchers: Give Kids a Chance Act of 2025 (H.R. 1262/S.932) Issues related to FDA Accelerated Approval Pathways
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
Client: FULCRUM THERAPEUTICS · Firm: THE MCMANUS GROUP
Education and advocacy regarding sickle cell disease, including H.R. 1796/S. 735- Sickle Cell Disease and Other Heritable Blood Disorders, Research, Surveillance, Prevention, and Treatment Act of 2025.
Education and advocacy regarding sickle cell disease, including H.R. 1796/S. 735- Sickle Cell Disease and Other Heritable Blood Disorders, Research, Surveillance, Prevention, and Treatment Act of 2025. Priority review vouchers: Give Kids a Chance Act of 2025 (H.R. 1262/S.932) Issues related to FDA Accelerated Approval Pathways
Strengthening Medicare for Patients and Providers Act
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION · Firm: THE MCMANUS GROUP
Issues related to access and physician reimbursement under Medicare Part B, including H.R. 879 - Medicare Patient Access and Practice Stabilization Act; H.R. 2474 - Strengthening Medicare for Patients and Providers Act; S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025 Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. H.R. 2484- Seniors' Access to Critical Medications Act of 2025. Issues related to prior authorization. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act Issues related to stark regulation of in office dispensing of Part D drugs. Issues related to the Provider Reimbursement Stability Act of 2026 (H.R.8163). Issues related to the Patients First Act of 2026 (H.R.9693)
Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
H.R. 2168, Baby Observation (BO's) Act
WEX HEALTH via THE MCMANUS GROUP
2026 · third_quarter · Q3
Issues related to making Health Savings Accounts and Health Reimbursement Arrangements more accessible and ubiquitous, including H.R. 548- HSA Modernization Act, H.R.919 - Chronic Disease Flexible Coverage Act, S. 2875 - Custom Health Option and Individual Care Expense (CHOICE) Act, H.R. 5463 - Choice Arrangement Act, S.2875 - CHOICE Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIALASE INC. via THE MCMANUS GROUP
2026 · third_quarter · Q3
Patient access and reimbursement of ophthalmic medical devices. Issues related to patient access to glaucoma treatment in 2027 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Proposed Rule (CMS-1850-P).
Education on ophthalmic medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCHE DIAGNOSTICS via THE MCMANUS GROUP
2026 · third_quarter · Q3
H.R.5269/2761 - RESULTS Act Issues related to Medicare coverage and reimbursement for FDA-designated breakthrough medical devices, focusing on establishing a transitional coverage period, including H.R. 5343/S. 1717- Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Q3
Issues related to infant monitoring in H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
H.R. 2168/S.3712, Baby Observation (BO's) Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) via THE MCMANUS GROUP
2026 · third_quarter · Q3
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers, including H.R. 3134, the Emergency Care Improvement Act.
Issues relating to the implementation of provisions included in Subtitle BB of PL.116-260- No Surprises Act, including the No Surprises Act Enforcement Act (H.R. 4710/S. 2420). Issues relating to the Federal Independent Dispute Resolution Operations proposed rule
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
LARGE UROLOGY GROUP PRACTICE ASSOCIATION via THE MCMANUS GROUP
2026 · third_quarter · Q3
Issues related to reforming and increasing transparency within the 340B Drug Pricing Program.
Issues related to access and physician reimbursement under Medicare Part B, including H.R. 879 - Medicare Patient Access and Practice Stabilization Act; H.R. 2474 - Strengthening Medicare for Patients and Providers Act; S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025 Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. H.R. 2484- Seniors' Access to Critical Medications Act of 2025. Issues related to prior authorization. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act Issues related to stark regulation of in office dispensing of Part D drugs. Issues related to the Provider Reimbursement Stability Act of 2026 (H.R.8163). Issues related to the Patients First Act of 2026 (H.R.9693)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INFUSION PROVIDERS ALLIANCE via THE MCMANUS GROUP
2026 · third_quarter · Q3
Advocating for access to and reimbursement for biosimilars. Issues related to vertical integration and white bagging. Issues related to patient access to products for asthma and allergies.
Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS LLC via THE MCMANUS GROUP
2026 · third_quarter · Q3
Access to autologous cellular immunotherapies in Medicare Part B. Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022.
Issues related to the Department of Veterans Affairs National Oncology Program's Prostate Cancer Oncology Clinical Pathway.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMBULATORY SURGERY CENTER ASSOCIATION via THE MCMANUS GROUP
2026 · third_quarter · Q3
Issues related to site neutrality. Issues related to provider and insurer payment transparency. S.1629 - Same Care, Lower Cost Act. Issues related to Patients Deserve Price Tags Act (S.2355/H.R.5582). Issues related to Lower Costs, More Transparency Act of 2026 (H.R.9393). Issues related to Health Care Price Certainty for All Americans Act (H.R.9645).
Advocacy for increased patient access and reimbursement to ambulatory surgical centers. Issues related to Medicare payment and beneficiary patients to ASCs. Medicare Beneficiary Co-Pay Fairness Act of 2025 (H.R. 3006/S. 1776) Outpatient Surgery Access Act of 2026 (H.R. 8091) Promoting Fairness for Medicare Providers Act of 2026 (H.R. 7863)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
2026 · third_quarter · Q3
Issues related to the 2025 End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) Final Rule (CMS-105-F), specifically the inclusion of oral-only drugs in the ESRD PPS Bundled Payment. Issues related to Most Favored Nation Drug Pricing Reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET via THE MCMANUS GROUP
2026 · second_quarter · Q2
Issues related to Artificial Intelligences approval in Medical Devices. Issues related to The SECURE Data Act (H.R. 8413).
Access and reimbursement of medical devices in Medicare program. Issues related to capping beneficiary copayments for Medicare beneficiaries in ambulatory surgery centers, included in Medicare Beneficiary Co-Pay Fairness Act of 2025(H.R. 3006/S. 1776) The Ensuring Patient Access to Critical Breakthrough Products Act (H.R. 5343/S. 1717)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WEX HEALTH via THE MCMANUS GROUP
2026 · second_quarter · Q2
Issues related to tax-advantaged savings accounts for Medicare beneficiaries, including the creation and regulation of Medicare Flex Fund Accounts to cover qualified medical expenses
Issues related to making Health Savings Accounts and Health Reimbursement Arrangements more accessible and ubiquitous, including H.R. 548- HSA Modernization Act, H.R.919 - Chronic Disease Flexible Coverage Act, S. 2875 - Custom Health Option and Individual Care Expense (CHOICE) Act, H.R. 5463 - Choice Arrangement Act, S.2875 - CHOICE Act H.R.1157 - ACCESS Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCHE DIAGNOSTICS via THE MCMANUS GROUP
2026 · second_quarter · Q2
H.R.5269/2761 - RESULTS Act Issues related to Medicare coverage and reimbursement for FDA-designated breakthrough medical devices, focusing on establishing a transitional coverage period, including H.R. 5343/S. 1717- Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Issues related to global trade and tariffs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Q2
H.R. 2168/S.3712, Baby Observation (BO's) Act
Issues related to infant monitoring in H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) via THE MCMANUS GROUP
2026 · second_quarter · Q2
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers, including H.R. 3134, the Emergency Care Improvement Act.
Issues relating to the implementation of provisions included in Subtitle BB of PL.116-260- No Surprises Act, including the No Surprises Act Enforcement Act (H.R. 4710/S. 2420). Issues relating to the Federal Independent Dispute Resolution Operations proposed rule
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
INFUSION PROVIDERS ALLIANCE via THE MCMANUS GROUP
2026 · second_quarter · Q2
Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
Advocating for access to and reimbursement for biosimilars. Issues related to vertical integration and white bagging. Issues related to patient access to products for asthma and allergies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FULCRUM THERAPEUTICS via THE MCMANUS GROUP
2026 · second_quarter · 2T
Education and advocacy regarding sickle cell disease, including H.R. 1796/S. 735- Sickle Cell Disease and Other Heritable Blood Disorders, Research, Surveillance, Prevention, and Treatment Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMBULATORY SURGERY CENTER ASSOCIATION via THE MCMANUS GROUP
2026 · second_quarter · Q2
Advocacy for increased patient access and reimbursement to ambulatory surgical centers. Issues related to Medicare beneficiary patients to ASCs. Medicare Beneficiary Co-Pay Fairness Act of 2025 (H.R. 3006/S. 1776) Outpatient Surgery Access Act of 2026 (H.R. 8091)
Issues related to site neutrality. Issues related to provider and insurer payment transparency. S.1629 - Same Care, Lower Cost Act. S.2355/H.R.5582 - Patients Deserve Price Tags Act. Issues related to Lower Costs, More Transparency Act of 2026 (H.R.9393)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Q2
Issues related to the 2025 End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) Final Rule (CMS-105-F), specifically the inclusion of oral-only drugs in the ESRD PPS Bundled Payment. Issues related to Most Favored Nation Drug Pricing Reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Q1
H.R. 2168/S.3712, Baby Observation (BO's) Act
H.R. 2168/S.3712, Baby Observation (BO's) Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · first_quarter · Q1
Issues related to the 2025 End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) Final Rule (CMS-105-F), specifically the inclusion of oral-only drugs in the ESRD PPS Bundled Payment. H.R.6214 - Kidney Care Access Protection Act Issues related to Most Favored Nation Drug Pricing Reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) via THE MCMANUS GROUP
2026 · first_quarter · Q1
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers, including H.R. 3134, the Emergency Care Improvement Act.
Issues relating to the implementation of provisions included in Subtitle BB of PL.116-260- No Surprises Act, including the No Surprises Act Enforcement Act (H.R. 4710/S. 2420). Issues relating to the Federal Independent Dispute Resolution Operations proposed rule
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
FULCRUM THERAPEUTICS via THE MCMANUS GROUP
2026 · first_quarter · Q1
Education and advocacy regarding sickle cell disease, including H.R. 1796/S. 735- Sickle Cell Disease and Other Heritable Blood Disorders, Research, Surveillance, Prevention, and Treatment Act of 2025. Priority review vouchers: Give Kids a Chance Act of 2025 (H.R. 1262/S.932) Issues related to FDA Accelerated Approval Pathways
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INFUSION PROVIDERS ALLIANCE via THE MCMANUS GROUP
2026 · first_quarter · Q1
Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
Advocating for access to and reimbursement for biosimilars. Issues related to vertical integration and white bagging.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMBULATORY SURGERY CENTER ASSOCIATION via THE MCMANUS GROUP
2026 · first_quarter · Q1
Advocacy for increased patient access and reimbursement to ambulatory surgical centers. Issues related to Medicare beneficiary patients to ASCs. Medicare Beneficiary Co-Pay Fairness Act of 2025 (H.R. 3006/S. 1776) Outpatient Surgery Access Act of 2026 (H.R. 8091)
Issues related to site neutrality. Issues related to provider and insurer payment transparency. S.1629 - Same Care, Lower Cost Act. S.2355 - Patients Deserve Price Tags Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Q4
H.R. 2168, Baby Observation (BO's) Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE